Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Kam Leung

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Canadian Journal of Applied Physiology = Revue Canadienne De Physiologie Appliquee|September 6, 2003
Regular moderate exercise training prevents decrease of CD4+ T-lymphocytes induced by a single bout of strenuous exercise in miceSai Chuen Fu, Lin Qin, Chi Kam Leung, et al.
BMC Complementary Medicine and Therapies|July 4, 2020
Patients' and clinicians' expectations on integrative medicine Services for Diabetes: a focus group studyKam Wa Chan, Pak Wing Lee, Crystal Pui Sha Leung, et al.
BMJ Open|August 7, 2016
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trialKam Wa Chan, Tai Pang Ip, Alfred Siu Kei Kwong, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Canadian Journal of Applied Physiology = Revue Canadienne De Physiologie Appliquee|September 6, 2003
Regular moderate exercise training prevents decrease of CD4+ T-lymphocytes induced by a single bout of strenuous exercise in miceSai Chuen Fu, Lin Qin, Chi Kam Leung, et al.
BMC Complementary Medicine and Therapies|July 4, 2020
Patients' and clinicians' expectations on integrative medicine Services for Diabetes: a focus group studyKam Wa Chan, Pak Wing Lee, Crystal Pui Sha Leung, et al.
BMJ Open|August 7, 2016
Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trialKam Wa Chan, Tai Pang Ip, Alfred Siu Kei Kwong, et al.
Pageof 1